The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Travel, Accommodations, Expenses - Abbvie
High, durable minimal residual disease negativity (MRD–) with venetoclax + rituximab (VenR) in relapsed/refractory (R/R) CLL: MRD kinetics from phase 3 MURANO study.
 
Peter Hillmen
Honoraria - Abbvie; Janssen
Research Funding - Abbvie (Inst); Gilead Sciences (Inst); Janssen (Inst); Pharmacyclics (Inst); Roche (Inst)
 
Arnon P. Kater
Consulting or Advisory Role - Abbvie; Acerta Pharma/AstraZeneca; Janssen; Roche; Sandoz
Research Funding - Abbvie; Acerta Pharma/AstraZeneca; Janssen; Roche; Sandoz
 
John Francis Seymour
Honoraria - Abbvie; Genentech; Roche
Consulting or Advisory Role - Abbvie; Genentech; Roche
Speakers' Bureau - Abbvie; Roche
Research Funding - Abbvie; Abbvie (Inst); Roche; Roche (Inst)
 
Anton W Langerak
Research Funding - Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - InVIvo Scribe (Inst)
 
Barbara Eichhorst
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen-Cilag; Novartis; Roche
Speakers' Bureau - Abbvie; Celgene; Gilead Sciences; Janssen-Cilag; Roche/Genentech
Research Funding - Abbvie; Gilead Sciences; Janssen; Roche
Travel, Accommodations, Expenses - GlaxoSmithKline; Mundipharma; Roche
 
Carolyn Owen
Honoraria - Abbvie; AstraZeneca; Gilead Sciences; Janssen; Merck; Roche
 
Sarit E. Assouline
Consulting or Advisory Role - Lundbeck; Roche Canada
Speakers' Bureau - Bristol-Myers Squibb; Paladin; Pfizer
 
Ann Janssens
Consulting or Advisory Role - Abbvie; Celgene; Gilead Sciences; Janssen; Roche; Sanofi
Speakers' Bureau - Abbvie; Amgen; Janssen; Roche
Travel, Accommodations, Expenses - Abbvie; Mundipharma; Roche
 
Paula Marlton
Honoraria - Abbvie; Amgen; Janssen-Cilag; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Janssen-Cilag; Novartis; Pfizer; Roche; Takeda
Speakers' Bureau - Janssen-Cilag
Travel, Accommodations, Expenses - Roche; Takeda
 
Xavier C. Badoux
No Relationships to Disclose
 
Rogier Mous
Employment - Abbvie (I); LEO Pharma (I)
Stock and Other Ownership Interests - Abbvie (I)
Honoraria - Gilead Sciences; Janssen-Cilag
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen-Cilag; MSD; Roche; Sandoz; Takeda
Research Funding - Gilead Sciences; Takeda
Travel, Accommodations, Expenses - Gilead Sciences; Takeda
 
Brenda Chyla
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Rod Humerickhouse
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Michelle Boyer
Employment - Genentech
 
Kathryn Humphrey
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Yanwen Jiang
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Elizabeth Punnoose
Employment - Genentech
 
Jue Wang
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Qun Jenny Wu
Employment - Genentech
 
Mehrdad Mobasher
Employment - Genentech
Stock and Other Ownership Interests - Roche